Search

everythinglearnresearchcommunity

for

Search:↓

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Treatment can improve survival and symptoms in dogs with Cushing's disease, but outcomes are unpredictable.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

Finasteride helps induce ovulation in nonresponder PCOS women.

PCOS is a common hormonal disorder in women that can lead to serious health problems.

Men with early hair loss may have higher insulin resistance and should be checked for related health issues.

Kir6.1 mutations in Cantú syndrome increase channel sensitivity and hyperpolarization, while SUR2B mutations do not.

Climate-related nutritional stress may cause hair loss in juvenile male Guadalupe fur seals.

Early balding in men is linked to metabolic syndrome, so screening is important for prevention.

Nutrease powder, a high-protein, low-carb supplement, can help manage Polycystic Ovary Syndrome symptoms, regulate periods, improve ovulation, and restore fertility.

Teak is a durable, termite-resistant wood with medicinal benefits.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Metformin improved menstrual cycle regularity and signs of hyperandrogenism in adolescent girls with type 1 diabetes but did not improve blood sugar control.

No treatment fully stops excessive hair growth in women, but various methods can help manage it effectively.

The cornified envelope is crucial for skin's barrier function and involves key proteins and genetic factors.

Antiandrogenic pretreatment for women with PCOS does not improve fertility outcomes and delays pregnancy.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

All women with Polycystic Ovary Syndrome (PCOS) in a study had at least one skin disorder, with the most common being excessive hair growth, acne, dark skin patches, hair loss, and oily skin.

Many women with postadolescent acne also have hormonal imbalances and are at higher risk for metabolic issues.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Some skin disorders might be linked to H. pylori infection, but more research is needed to confirm this.

New drugs are improving treatment for hormone-related diseases in small pets.

Certain brain hormones and chemicals are linked to the development of Polycystic Ovary Syndrome.

Gene therapy shows promise for enhancing physical traits but faces ethical, safety, and regulatory challenges.